Tag: Qwo

Momentum Builds as Malvern-Based Endo Gets Closer to Launch of Its Potential Blockbuster Product

After pushing the launch of its new cellulite treatment, Qwo, to this spring due to the pandemic, Malvern-based Endo International has been building momentum…

Malvern’s Endo Plans to Restructure, Eliminate 560 Positions

Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has announced plans to restructure the company and eliminate 560 jobs…

Malvern’s Endo to Acquire Local Company for $658 Million and Bring Its Cellulite-Fighting Drug to Market

Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano…

New Drug from Malvern’s Endo the First Injectable Treatment for Cellulite Cleared by the FDA

Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has received marketing approval from the FDA for its injectable drug…